glp 1 trial GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Randomised trial comparing weight loss
Description
Development of an instrument to assess expectations of and preference for an insulin injection pen compared with the vial and syringe
Pilla, S
The risk of hypoglycemia is significantly reduced since these effects are in close relationship with glucose blood levels (14)
Expected indication launch timelines for selected pipeline candidates Pharmaceutical companies are investing significantly in oral GLP-1s
The majority are women about two-thirds of the plaintiffs in USA TODAYs sample
H., Renstrom, E
